SquamousCellCarcinomaofSkin near Plant City, FL

Care Philosophy: Dr Fontaine received his medical degree from McGill University in Montreal, Canada, and completed his general surgery residency at Boston University. In 2006, he graduated as chief resident in thoracic surgery at Brigham and Women's Hospital - Harvard Medical School. Dr Fontaine began his thoracic surgery practice at University of Montreal but was then recruited to become part of the Department of Thoracic Surgery at Brown Medical School in Providence, RI. He was in charge of developing a thoracic surgery program at one of Brown University's teaching hospitals. In 2011, Dr Fontaine joined Moffitt Cancer Center in Tampa, FL - the 3rd largest cancer center in the United States.

Care Philosophy: ``Out in the community, it's rare that you would have a medical, radiation, and surgical oncologist who see just genitourinary cancers as we do.`` Dr. Mayer Fishman is a genitourinary oncologist and a member of the immunotherapy and experimental therapeutics programs at Moffitt Cancer Center. He is also an associate professor on oncology and internal medicine at the University of South Florida College of Medicine.

Care Philosophy: Dr Zhang is a Genitourinary Oncologist and Interim Vice Chair of the Department of Genitourinary Oncology at Moffitt Cancer Center. He is also an Associate Professor of Oncology and Internal Medicine at the University of South Florida College of Medicine. His primary research interest is in integrating tumor evolution dynamics into the treatment for advanced prostate cancer. As the clinical research Director of Moffitt Cancer Center's Genitourinary Oncology Department, he has been the Principal Investigator (PI) and Co-Investigator of more than 50 phase I, II, and III clinical studies since joining Moffitt in July 2010.

Care Philosophy: Dr Tanvetyanon is a medical oncologist with expertise in lung cancer, mesothelioma and thymic carcinoma. Services offered include a wide array of clinical trials, immunotherapy programs, and hyperthermic intraperitoneal chemotherapy (HIPEC) for malignant mesothelioma. In addition, Dr Tanvetyanon is experienced in managing abnormal findings from lung cancer screening. Dr Tanvetyanon is a health outcomes researcher as well as an epidemiologist. To date, he has published over 50 peer-review articles in medical journals including Journal of Clinical Oncology, Annals of Oncology, Head & Neck and Journal of Thoracic Oncology.

Biography: Dr. Thomas Rutherford, MD is an Obstetrics /amp Gynecology Specialist who practices in Tampa, FL. He is 71 years old. Dr. Thomas Rutherford, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Care Philosophy: Dr. Fletcheris an Associate Professor of Medicine within the Division of Hematology and Oncology. He is a Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee.

Care Philosophy: Dr Christine Sam is an Assistant Member in the Department of Individualized Cancer Management/Senior Adult Oncology Program. Dr Sam received her medical degree from Michigan State University College of Human Medicine in East Lansing. She completed an Internal Medicine Residency at University of Michigan Health Systems in Ann Arbor. She completed her Hematology and Medical Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine in Tampa. Dr Sam's primary clinical interest is the treatment of cancer in older patients and developing care plans tailored to their individual needs. Her focus is the treatment of breast, gastrointestinal, and genitourinary malignancies.

Care Philosophy: Dr Druta earned her MD degree from the University of Medicine and Pharmacy Carol Davila, Romainia. She completed an Internal Medicine Residency and Hematology/Medical Oncology Fellowship at the University of South Florida at Moffitt Cancer Center. Dr Druta most recently completed a Sarcoma Medical Oncology Fellowship (Willie Tichenor Sarcoma Fellowship) at MD Anderson Cancer Center. Dr Druta's clinical interest is in the development of clinical trials focusing on targeted therapeutics specific to sarcoma patients. Her research interest is in the translational aspects of sarcoma biology focusing specifically on Well-differentiated/Differential Liposarcoma and Leiomyosarcoma.

Care Philosophy: Dr Shafique earned his Medical Degree from the University of Virginia School of Medicine and completed an Internal Medicine residency at Duke University Medical Center and a subsequent Hematology and Medical Oncology fellowship at the University of South Florida/Moffitt Cancer Center. Although Dr Shafique devotes most of his time to treating patients with lung cancer, he also sees patients with a broad spectrum of diagnoses as part of early-phase clinical trials. Additionally, he manages medical oncology treatments for patients with Gynecologic malignancies.

Care Philosophy: Dr Sameh Gaballa is an AssociateMember in the Moffitt Cancer Center Department of Malignant Hematology. Dr Gaballa earned his MD from Aims Shams University in Cairo, Egypt. He completed an Internal Medicine Residency and a Hematology and Medical Oncology Fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. He then completed a Stem Cell Transplantation and Cellular Therapy Fellowship at the University of Texas MD Anderson Cancer Center. Dr Gaballa previously practiced in the Thomas Jefferson University, Division of Hematologic Malignancies and Blood and Marrow Transplantation.

Care Philosophy: Dr Walker received her MD from University of Rochester School of Medicine and Dentistry. She completed an Internal Medicine Residency and a Hematology/Oncology Fellowship at the University of Rochester, New York. She joins us from The Ohio State University, where she served as a Professor in the Department of Internal Medicine, Division of Hematology. Dr Walker's clinical interests are in the care of patients with myeloid malignancies, specifically acute myeloid leukemia and myelodysplastic syndromes. She is particularly interested in identifying ways to deliver care that maximizes resource utilization and achieves superior patient satisfaction.

Care Philosophy: Dr Rachid Baz is a board-certified hematologist and medical oncologist who came to Moffitt in 2008 from Cleveland Clinic. Currently, Dr Baz is the Myeloma Section Head in the Department of Malignant Hematology at Moffitt Cancer Center and co-Director of the Pentecost Family Myeloma Research Center. He has developed a special expertise in managing patients with plasma cell disorders such as multiple myeloma, monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma, primary systematic amyloidosis, and Waldenstrom's macroglobulinemia (WM). Among other awards, he was the recipient of the Junior Clinical Science Award at Moffitt, and the University of South Florida Outstanding Resident Teaching Award.

Care Philosophy: Dr Andre Beer Furlan is a skull base and endovascular neurosurgeon at Moffitt Cancer Center and Assistant Professor of Oncologic Sciences at the University of South Florida. Dr Beer Furlan earned his MD and PhD degrees from the University of Svo Paulo (FMUSP), a top ranked university in Latin America. He completed the neurosurgery residency at the same institution and practiced as a neurosurgeon and skull base surgeon in Sao Paulo, Brazil before moving to the United States.

Care Philosophy: Dr Blue earned his MD at Meharry Medical College, Nashville, Tennessee. Dr Blue completed an Internal Medicine Residency in the Department of Medicine at Washington University School of Medicine, St. Louis, Missouri, and d a Hematology/Oncology Fellowship in the Department of Medicine at Saint Louis University School of Medicine. Dr Blue recently completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. Dr Blue's clinical interests include treatment of plasma cell disorders and evaluation of patients pre and post bone marrow transplant. His research interests include reducing health disparities and improving health outcomes for plasma cell dyscrasias.

Care Philosophy: Dr Locke is a medical oncologist and translational researcher in the Department of Blood and Marrow Transplant and Cellular Immunotherapy. He leads the Immune Cell Therapy (ICE-T) initiative at Moffitt, an integrated cross-departmental translational team. Dr Locke is a clinical research leader in the field of Chimeric Antigen Receptor (CAR) T cell therapy, acting as a national P.I. for several pivotal trials of anti-CD19 CARs for lymphoma. In addition, Dr Locke is translating findings from his laboratory into new cellular immunotherapies such as the Moffitt created whole protein survivin tumor vaccine for multiple myeloma. Dr Locke graduated with a B.S.

Care Philosophy: Dr Pinilla-Ibarz has been at Moffitt since 2006 and holds the rank of Senior Member and Head of Lymphoma Section in the Department of Malignant Hematology. Dr Pinilla-Ibarz received the 2016-17 Moffitt Physician of the Year Award. He was also the recipient of the ASCO young investigator award in 2003 and the ASCO career development award in 2007. Dr Pinilla-Ibarz is nationally and internationally known for his expertise in chronic leukemia and he currently has over 120 peer-reviewed publications. He has received grant support through the Leukemia & Lymphoma Society and also from multiple industry partners. His clinical interests include chronic myeloid leukemia and chronic lymphoid leukemia.